How to Participate
Recorded webinar available from Sept 11 to mid October at ONS Bridge: https://gateway.on24.com/wcc/eh/2407130/category/34202/on-demand-library
NOTE: You must also be registered for ONS Bridge at: www.ONS.org/store/ons-bridge-2020-registration.
In late October, the recorded webinar will be available on this webpage.
Target Audience
Nurses and nurse practitioners involved in the care of patients with hematologic malignancies.
Description
Nurses from three cancer centers discussed the nurse's role in preparing patients and caregivers for the CAR T-cell treatment process, assessment, monitoring for and managing side effects, and communication with the patient's community healthcare team to transition patient care back. Following a patient from initial treatment discussion, symposium attendees will be able to provide feedback on patient care for the case, in this interactive session. With CAR T therapy and follow-up care expanding beyond the major centers, nurses are essential members of the treatment team.
Learning Objectives
At the conclusion of this program, participants will be able to:
- Provide an overview of chimeric antigen receptor (CAR) T-cell therapy and the blood cancers and solid tumors under study for treatment
- Explain the nurse's role in assessment, monitoring for and managing side effects of treatment
- Describe the nurse's role in preparing patients and family members about the CART process and potential side effects of treatment
- Address the need for communication with a patient’s community oncologist and healthcare team to transition care after CAR T-cell therapy
Faculty
Sherry Adkins, RN, MSN, CNS, ANP-C
The University of Texas
MD Anderson Cancer Center
Houston, TX
Heather DiFilippo, MSN, CRNP
University of Pennsylvania Health System
Philadelphia, PA
Ilene Galinsky, BSN, MSN, NP-C
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Boston, MA
Kathleen McDermott, RN, BSN, OCN®, BMTCN®
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Boston, MA
Continuing Education Information
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Participants must attend the free webinar in its entirety, submit the online evaluation form, and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.
Providers
This program is provided by The Leukemia & Lymphoma Society.
Supporters
This program is supported by Bristol Myers Squibb Company; Kite, A Gilead Company and Novartis Pharmaceuticals Corporation
NOTES:
- Participants gain access to the recorded webinar by going to the On Demand Library at ONS Bridge at https://gateway.on24.com/wcc/eh/2407130/category/34202/on-demand-library
- You must also be registered for ONS Bridge at: www.ONS.org/store/ons-bridge-2020-registration.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact ProfEducation@LLS.org